Version 5.0 of the Clinical Practice Protocols manual is now available here » This version contains many changes including:

New:

  • Hyperkalemia care plan
  • Physician/ medical consultation policy
  • Medication administration in rare, life threatening conditions policy
  • Penthrox monograph
  • Tranexamic Acid (TXA) monitoring added to Interfacility Transfer of Patients Receiving Medication
  • TXA added to Shock Protocol

Alterations:

  • Agitated patients replaces Psychiatric emergencies
  • Medical control is removed for all ACP protocols
  • Links embedded in each protocol with a “Go to ….” statement. These links will take you to the stated protocol.
  • Version history flipped: newest revisions are listed first

Additions:

  • Conflict with OLMC - PCP added to #2
  • EMR added to Medication Administration (Oral)
  • EMR added to Acetaminophen
  • Hemostatic agents added to External bleeding protocol


Education Information for TXA and Hyperkalemia

The fall 2018 update to the Paramedic Clinical Practice Protocols manual contains two new medications: tranexamic acid and calcium.

Primary Care Paramedics and higher will now be able to monitor tranexamic acid (TXA).

Advanced Care Paramedics have been approved for the administration of tranexamic acid (TXA). In addition, ACPs have a new hyperkalemia protocol which includes the use of calcium.

The Education Committee has developed training packages for the new medications and patient care plan being introduced into paramedic practice. All members PCP and higher are required to do the training applicable to their licence level. Please note that the training on each module must be completed in one sitting. If you end the session, you will be required to start from the beginning of that module.

No paramedic may monitor or administer these new medications without first completing the education.

The training modules can be found under Protocols / Protocol Training »

This training format may be provided on occasion by SCoP, but will not be a replacement for the continuing education process currently in place. This training is not eligible for CME credits.

SCoP wishes to thank the development team made up of Education Committee members, as well as the members who developed the initial protocol proposals:

Tim Hillier
Bill Fischer
Mike Hengstler
Darcy McKay
Noel Dunn
Jeff Maxin
Tianna Langelotz
Destin Ash
Richard Kenkel